November, 2025
In November, sentiment toward SUSS MicroTec improved despite weak third-quarter results. The company reported Q3 revenue of €118 million, an EBIT margin of 10.5%, and order intake of €70 million, reflecting continued margin pressure and subdued demand. Management confirmed its full-year revenue guidance of €470–510 million, while maintaining a reduced EBIT margin outlook of 11–13%, supported by tighter cost controls and capacity adjustments.
Investor confidence strengthened after management signaled a clear rebound in order momentum expected in Q4, based on concrete customer inquiries. This outlook triggered a series of analyst upgrades from Deutsche Bank, Jefferies, and UBS, citing improving customer sentiment, AI-related demand, and expectations that Q3 marked the cyclical low in orders.
At its Capital Markets Day on November 17, SUSS MicroTec outlined ambitious long-term targets, aiming to grow annual revenue to €750–900 million by 2030, alongside a significant recovery in profitability driven by new technologies such as hybrid bonding and wafer cleaning.
Overall, November marked a shift from near-term weakness toward cautiously improving expectations for order recovery and medium-term growth.
October, 2025
SUSS MicroTec issued another profit warning, cutting its 2025 margin outlook for the second time in three months after preliminary Q3 2025 results came in well below expectations. The company reported a Q3 EBIT margin of 10.5% (vs ~12.5% consensus) and a gross margin of 33.1%, also materially under market expectations. Management said no meaningful margin improvement should be expected in Q4.
As a result, SUSS lowered its full-year 2025 guidance to a gross margin of 35–37% (from 37–39%) and an EBIT margin of 11–13% (from 13–15%; down from 15–17% as recently as late July). The main drivers cited were costs related to the new Taiwan (Zhubei) site, lower business volume and weaker fixed-cost absorption, and an unfavorable product/customer mix.
Revenue guidance was maintained at EUR 470–510 million, with EUR 384.4 million generated over the first nine months. However, Q3 order intake fell to EUR 70 million (vs EUR 84 million in Q3 2024), prompting management to consider cost-saving measures beyond near-term cost discipline. The stock reaction was sharply negative, with shares down roughly 17–19% in early/pre-market trading.
August, 2025
In early August, SUSS MicroTec reported a very strong Q2, with revenue of EUR 143.2 million, well above the IBES estimate of EUR 118.8 million, while confirming its reduced full-year EBIT margin guidance of 13–15%. This underscored continued top-line strength, despite earlier warnings about margin pressure from expansion and one-off costs.
At the same time, the stock remains sensitive to macro and regulatory risks. Broader market concerns include new U.S. tariffs, which could affect global semiconductor demand, and later in August BaFin flagged inaccuracies in SUSS MicroTec’s consolidated financial statements as of end-2024, adding a governance-related overhang. Overall, results point to robust revenues, but investor focus remains firmly on margins, compliance issues, and external trade risks.
July, 2025
In July, SUSS MicroTec faced renewed pressure from both analysts and revised margin expectations, despite maintaining its revenue outlook. Early in the month, the shares slipped around 2% after Oddo BHF downgraded the stock to “Neutral” from “Outperform”, weighing on sentiment.
Later in July, the company cut its full-year EBIT margin guidance to 13–15% from 15–17%, citing one-off costs and a weaker-than-expected second-half profile. Margin pressure stemmed from start-up costs for the new Taiwan production site, write-downs on a discontinued project, and higher R&D staffing expenses. While the first-half EBIT margin reached 15.7%, management warned that slower revenue growth, a less favorable product mix, and overlapping cost burdens would weigh on profitability in H2.
Importantly, the revenue forecast was left unchanged at EUR 470–510 million, with EUR 266.4 million already generated in the first half, providing some top-line visibility. Nevertheless, the guidance cut triggered a sharp market reaction, with shares falling around 10% in pre-market trading, reflecting concerns that earlier share price gains had outpaced underlying business momentum.
Overall, July marked a shift in focus from revenue growth to cost execution and margin sustainability, as investors reassessed near-term profitability amid expansion-related expenses and a softer second-half outlook.
June, 2025
Monthly reports point to solid operating performance at SUSS MicroTec, tempered by rising macro- and demand-related concerns. The company posted a strong start to 2025, with Q1 sales up 31.8% to EUR 123.2 million and an EBIT margin of 16.6%, while reconfirming full-year guidance of EUR 470–510 million in revenue and a 15–17% EBIT margin, excluding potential tariff effects.
At the same time, order intake fell to EUR 88.1 million, indicating some normalization after last year’s record demand. Analysts have grown more cautious on the sustainability of AI-related investment, noting that key customers such as Micron and Samsung have already installed substantial capacity, which may delay new orders. Following these comments, shares dropped by more than 10%, reflecting heightened sensitivity to AI-cycle and trade-policy uncertainty, despite the company’s fundamentally strong execution.
May, 2025
In early May, SUSS MicroTec reported a strong start to 2025, while reiterating caution around trade and tariff-related macro risks. Q1 sales rose 31.8% year-on-year to EUR 123.2 million, driven in particular by robust demand linked to artificial intelligence applications. Operating performance improved, with EBIT up 37% to EUR 20.4 million and the EBIT margin increasing to 16.6% (from 15.9% a year earlier). The gross margin eased slightly to 37.9%, remaining broadly stable at a high level.
Despite the strong revenue and earnings growth, order intake declined to EUR 88.1 million from EUR 98.3 million in the prior-year quarter, signalling some moderation after last year’s record levels. Management emphasized that there have been no order cancellations or deferrals so far, but pointed to heightened uncertainty in the market, particularly related to U.S. trade and tariff policy, which could affect global semiconductor demand.
The company confirmed its full-year 2025 guidance, excluding potential tariff effects, targeting revenue of EUR 470–510 million and an EBIT margin of 15–17%. Overall, the update highlighted strong operational momentum and profitability, balanced against increasing external uncertainty and softer near-term order intake.
March, 2025
At the end of March, SUSS MicroTec presented a constructive 2025 outlook, while analyst concerns over AI-related demand triggered a sharp share price correction.
Management guided for another record year in 2025, targeting revenue of EUR 470–510 million (2024: EUR 446 million), implying roughly 10% growth. The EBIT margin is expected at 15–17%, broadly in line with 2024 levels, as higher investments in IT, digitalization, and R&D are set to weigh on margins in the short term. Potential tariff-related risks are not yet reflected in the guidance. For 2024, the company reported a net profit of EUR 110.3 million, supported by strong operations and a EUR 54.5 million gain from the sale of SUSS MicroOptics, and proposed a dividend of EUR 0.30 per share, up from EUR 0.20.
Despite the solid outlook, shares fell more than 10% after negative analyst commentary. Jefferies and Deutsche Bank warned of weakening AI infrastructure demand, noting that key customers such as Micron and Samsung have already installed substantial capacity, potentially delaying new orders. Analysts expect Q1 order intake to be flat versus Q3, implying a year-on-year decline of around 10%, and Jefferies forecast FY 2025 revenue of EUR 482 million, slightly below the midpoint of company guidance. As a result, several banks cut price targets sharply, pushing the stock to the bottom of the SDAX.
Overall, the news flow juxtaposed strong financial performance and optimistic top-line guidance with rising skepticism about near-term AI-driven demand, highlighting increased uncertainty around order momentum despite a fundamentally solid starting position for 2025.
January, 2025
In January, SUSS MicroTec was pulled between more cautious sell-side cycle views and materially stronger-than-guided company results, with AI-driven market narratives amplifying volatility.
Jefferies argued the semiconductor cycle is likely to peak in H1 2025 and then plateau through 2025, with a clearer rebound for auto/industrial chipmakers in 2026. It warned that equipment suppliers face slower AI-demand growth and limited 2026 visibility, and downgraded SUSS MicroTec to “hold” from “buy” on demand concerns.
Against that backdrop, SUSS MicroTec reported preliminary 2024 results that significantly exceeded its own guidance: FY sales ~EUR 445m (vs EUR 380–410m guided) and an EBIT margin ~17.5% (vs 14–16% guided), implying EBIT ~EUR 78m (2023: EUR 28m). Q4 orders rose sharply to EUR 147m, lifting full-year orders to a record ~EUR 423m. The market reaction was strong, with the shares jumping up to ~35.5%, after having fallen sharply earlier in the month on critical analyst commentary and China-related concerns.
Sector sentiment then drove additional swings: SUSS MicroTec rose with AI-infrastructure enthusiasm around the U.S. “Stargate” investment plan, but later dropped sharply amid broader European tech sell-offs linked to concerns around China’s DeepSeek model.
December, 2024
In December, SUSS MicroTec shares came under pronounced pressure as part of a broad sell-off in European semiconductor stocks, triggered by disappointing guidance from Micron Technology. Micron’s quarterly outlook fell well short of market expectations, signalling continued weakness in consumer demand, particularly in memory chips for smartphones and PCs.
The negative guidance weighed heavily on sector sentiment and prompted profit-taking across semiconductor equities. In early trading, SUSS MicroTec shares dropped by around 6%, underperforming the broader market and moving to the lower end of the SDAX. Market participants characterized Micron’s outlook as sentiment-negative for the entire sector, reinforcing concerns that the cyclical recovery in semiconductors may be delayed.
The sell-off was not company-specific, but reflected systemic sector weakness, with sharp declines also recorded across major European semiconductor names. Micron’s shares themselves fell sharply in U.S. after-hours trading, marking their steepest decline since early 2020 and amplifying risk aversion toward the sector globally.
Overall, the month’s share price weakness in SUSS MicroTec was driven by external macro- and industry-level factors, rather than changes in the company’s operational outlook. The episode underscores the stock’s high sensitivity to global semiconductor cycle sentiment, particularly developments in memory markets and end-consumer demand expectations.
November, 2024
In November, SUSS MicroTec reported strong operational momentum alongside a strategic expansion of its manufacturing footprint. The company announced the lease of a new production site in Taiwan, which will double local production capacity to 6,300 square meters. The expansion involves an expected investment of EUR 15–20 million and is intended to support regional demand growth, while having no direct impact on German production sites.
Operationally, SUSS MicroTec delivered robust financial performance over the first nine months of the year. Revenue rose 46% year-on-year to approximately EUR 295 million, supported by strong execution and favorable product mix. Profitability improved markedly, with the EBIT margin increasing to around 16%, compared with a mid-single-digit margin in the prior-year period. Gross margin expansion further underlined the company’s improved operating leverage.
Order intake for the first nine months reached EUR 276 million, slightly below the prior-year level, reflecting more moderate demand in the third quarter. Management noted that this slowdown was anticipated, particularly as orders from Chinese customers normalized after an extended period of exceptionally high demand—an observation consistent with trends reported by other semiconductor equipment suppliers.
Despite this moderation, order backlog remained strong at over EUR 430 million, providing high revenue visibility well into 2025. Management therefore confirmed its full-year 2024 guidance, targeting revenue of EUR 380–410 million and an EBIT margin of 14–16%. Overall, the month reinforced the picture of profitable growth, solid backlog visibility, and disciplined capacity expansion, positioning SUSS MicroTec well despite near-term demand normalization in parts of the market.
October, 2024
During the month, SUSS MicroTec shares came under pressure, primarily following a negative analyst reassessment amid worsening sector visibility for 2025. The key development was a downgrade by Stifel, which cut its rating to Hold from Buy and lowered its price target to EUR 60 from EUR 70. In response, the stock declined by around 4.3%, placing it among the weakest performers in the SDAX on the day.
The downgrade was driven largely by broader semiconductor industry concerns, rather than company-specific operational news. Stifel cited weaker-than-expected 2025 guidance from ASML, which it views as having negative implications for SUSS MicroTec’s photomask equipment business. This segment is considered the group’s most profitable over the cycle, meaning that any demand slowdown or margin pressure is expected to disproportionately affect overall profitability.
Given the reduced visibility into semiconductor capital expenditure trends, Stifel expects SUSS MicroTec shares to remain range-bound until clearer signals emerge for 2025. Overall, the month was characterized by sentiment-driven weakness, reflecting sector-wide caution rather than new company-specific disclosures.